Differential gene expression in either CD3+ lymphocytes or CD11b+ myeloid cells due to Class IIa HDAC inhibitor treatment

GSE76659

Mus musculus

13 Downloadable Samples

Affymetrix Mouse Gene 1.0 ST Array (mogene10st)

Submitter Supplied Information

Description

The aim of this study was to identify differential gene expression resulting from the inhibition of class IIa HDACs in the CD3+ or CD11b+ cells residing in MMTV-PyMT tumors.

PubMed ID

28273064

Publication Title

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.

Total Samples

Submitter’s Institution

GSK

Authors

Guerriero JL, Sotayo A, Ponichtera HE, Castrillon JA, Pourzia AL, Schad S, Johnson SF, Carrasco RD, Lazo S, Bronson RT, Davis SP, Lobera M, Nolan MA, Letai A

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-76659

No rows found